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A B S T R A C T
Caries preventive effect of a sugar-free chewing-gum containing Magnolia Bark Extracts and Xylitol in high-risk
adults was investigated (NCT02310308). Two-hundred seventy-one high-caries-risk subjects were assigned to
three groups: Polyols (Pols), Xylitol (Xyl) and Xylitol plus Magnolia (Xyl + Mag). Caries lesions, gingival
bleeding, mutans streptococci (MS), and plaque pH were re-evaluated after 2 years in 64 Pols, 66 Xyl and 64
Xyl + Mag subjects. Net caries increment was evaluated using the Mann–Whitney U test. Caries increment was
significantly different among groups at the 2-year evaluation (t3) (p < 0.01). MS concentration and plaque pH
as mean Areas Under the Curves (AUC) differed among groups at t2 (MS p = 0.02, AUC5.7 p = 0.03 and AUC6.2
p = 0.04,) and t3 (p = 0.03, p = 0.04 and 0.05, respectively). Significantly lower gingival scores were observed
in Xyl + Mag and Xyl groups (p = 0.01 and<0.01, respectively). Chewing-gum containing Xylitol and
Magnolia has a higher preventive effect compared to Xylitol alone.
1. Introduction
Dental caries continues to be one of the most prevalent human
diseases, despite the availability of various preventive strategies
(Bowen & Koo, 2011). Since it is difficult to control human behaviour,
many caries-preventive measures have been proposed among which the
use of fluoride toothpastes twice daily is the main and appreciated
measure. However, the actual skewed caries figure suggests the need of
developing new and effective preventive approaches, especially for
high-risk groups (Bagramian, Garcia-Godoy, & Volpe, 2009; Marcenes
et al., 2013). The use of sugar-free chewing gums may contribute to
prevent dental caries (Deshpande & Jadad, 2008; nostro lavoro xyli-
tolo). The increase of stimulated saliva flow rate promotes oral clear-
ance and increases the buffering capacity, contributing to neutralise the
plaque-pH (Dodds, 2012). It is widely known that the consumption of
Xylitol contributes to reduce plaque amount, the numbers of mutans
streptococci (MS) and the caries increment (Campus et al., 2013;
Soderling, 2009).
Several phytochemicals have shown potential pharmacological or
antimicrobial activity including oral bacteria (Abreu, McBain, &
Simões, 2012; Ciric et al., 2011; Komarova et al., 2017). Magnolia Bark
Extract (MBE) is a plant extract obtained from the bark of Magnolia
officinalis (Magnoliaceae), widely used in traditional Chinese medicine
that is isolated by CO2 super critical fluid extraction. Concentrated
Magnolia Bark Extract is considered a novel food in Europe and it is
listed in the EU Regulation 2017/2470. MBE was in vitro recently tested
against multi-species oral biofilms (Fernández, Aspiras, Dodds,
González-Cabezas, & Rickard, 2018; Komarova et al., 2017), showing a
significantly reduction of biomass, thickness and viability of oral bio-
films.
A variety of pharmacological properties are ascribed to the two
main constituents (97%), magnolol [4-Allyl-2-(5-allyl-2-hydroxy-
phenyl)phe nol] and its isomer honokiol [2-(4-hydroxy-3-prop-2-enyl-
phenyl)- 4-prop-2-enyl-phenol] (Lo, Teng, Chen, Chen, & Hong, 1994;
Wang, Ho, Chang, & Chen, 1995), including the limitation of the
growth of several oral pathogens (Campus et al., 2011; Chang, Lee, Ku,
Bae, & Chung, 1998; Greenberg, Urnezis, & Tian, 2007; Ho, Tsai, Chen,
Huang, & Lin, 2001; Li & Xu, 2004). Unfortunately, the mechanism of
action of MBE against specific oral bacteria is still unknown as the
majority of studies on MBE focused on the general antimicrobial effect
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of MBE against bacteria. Specific affinity of MBE for oral Gram-negative
bacteria increasing their cell surface hydrophobicity was described
(Wessel et al., 2017). In vitro, magnolol demonstrated an high bacter-
icidal activity against Streptococcus mutans, while honokiol activity was
weaker (Sakaue et al., 2016).
We have previously reported the effect of a daily-administered
sugar-free chewing gum containing MBE in a sample of adults at high
caries-risk (Campus et al., 2011). The short-term use of MBE chewing
gum has demonstrated beneficial effects on oral health, including re-
duction of salivary MS, plaque formation (bleeding scores) and acid-
ogenicity and bleeding on probing (Campus et al., 2011; Komarova
et al., 2017).
In a previous paper (Cocco et al., 2017) the long-term effect of a
low-dosage Xylitol chewing-gum was also described. In this study the
caries preventive effect of the long-term use of a sugar-free chewing-
gum containing MBE and Xylitol in a high-risk adult population was
investigated through a three-arm randomised clinical trial.
2. Methods
This paper reports on findings obtained in a larger research project
that examines the effect of several functional foods supplied through
chewing gums on caries risk factors and caries lesion development in an
adult population.
2.1. Ethics approval
The present study was carried out in Sassari (Italy), lasted from
September 2012 to June 2015. The study was designed as a randomized
clinical trial, approved by the Ethics Committee of the University of
Sassari (n°1083/L 23/07/2012), and registered (Protocol Registration
Receipt NCT02310308) at http://www.clinicaltrial.gov. All performed
procedures were in accordance with the ethical standards of the 1964
Helsinki Declaration and its later amendments.
2.2. Physical, chemical characterization and extraction procedure of the
Magnolia Bark extracts
The bark of Magnolia officinalis Rehder spp. Biloba has been col-
lected from the trunk of trees grown in China. Harvesting time was from
April to June. The external part of the bark is hard and grey-brown,
while immediately below the surface it fades toward yellow and then
even tending to red with slight longitudinal stripes. The gatherers take
care to collect the bark complete with the three areas. The raw bark is
cleaned from dirt and impurities through a triple water washing and
dried in single or double rolls at 50 °C till residual moisture is below
9%. The dried bark is crushed and extracted in supercritical carbon
dioxide (35 °C, 1200–1400 l/h, 3 h 30 min). The raw extract is dis-
solved in ethanol and crystallized therefrom under vacuum at 50 °C.
The refined extract is dried, sterilized, and sieved below 180 μm. The
outcome is a light brown powder. Magnolol and honokiol were de-
termined by HPLC-DAD, as suggested in Tsai and Chen (1992), and
accounted for 87.2% and 10.8% of the extract, respectively. All other
components were present in traces (total Eudesmol: 0.0093%, Moisture:
0.70%, Arsenic: 0.010%; Lead: 0.086%).
2.3. Chewing gums characteristics
All chewing gums were produced and supplied by Perfetti Van Melle
SpA (Lainate, Italy). The polyols chewing gum was a sugar-free gum
containing 28% Isomalt, 31% Sorbitol, 9% Mannitol and 1% Maltitol
syrup. Xylitol chewing gum contained 30% of Xylitol, 26% Sorbitol,
11% Mannitol and 1% Maltitol syrup.
Magnolia chewing gum contained the same ingredients and per-
centages of the Xylitol group plus 0.17% of MBE of the gum weight. All
three types of chewing gums weighed 1.4 g each and were identical in
colour, shape and taste. Chewing gums were supplied in plain white
containers coded as ‘green’, ‘yellow or ‘blue’ according to the group.
The code was sealed by an independent monitor and not broken until
the statistical analysis was finalized.
2.4. Analysis of Magnolia Bark Extract in chewing gum
The release of Magnolol and Honokiol from the sugar free chewing
gum was analysed by HPLC equipped with a photodiode-array UV de-
tector (DAD) as reported in the literature (Tsai & Chen, 1992), (Agilend
1200 Infinity), with a reference wavelength of 209 nm. A column C-18
was employed, type Lichrospher RP 100, 5 µm – Merck. The column
temperature was set at 22 °C with a flow rate of mobile phase at 1.0 ml/
min (CH3CN/H2O/H3PO4 85% 65/35/0,1 volume ratio). To determine
the concentration of magnolol and honokiol in the chewing dragees of
the present study prior to chewing, the coating of ten gum pieces was
dissolved in 250 ml of distilled water. The solution was blended with
250 ml of ethanol, filetered and analysed by HPLC. To determine the
release of magnolol and honokiol from the study chewing gum, ten
subjects (5M, 5F) chewed one piece each of sugar free chewing gum
dragee, containing MBE in the coating. The subjects were instructed to
chew at their normal pace for 5 min. The gum bolus was then collected
from the subjects, homogenized and dissolved in chloroform. The so-
lution was analysed by HPLC as described. The amounts of magnolol
and honokiol were determined according to calibration curves obtained
through external starndards. The percentage of magnolol and honokiol
released during mastication was calculated considering as 100% the
respective amounts contained in the gum prior to chewing.
2.5. Study population
The sampling technique and methods are described in detail in the
previous paper (Cocco et al., 2017). Briefly, sample size for preliminary
screening was performed trough G*Power 3.1.3 for Apple, using logistic
regression with an odds ratio of 1.8, an error probability of 0.04; the
total sample was set at 312.
In order to get statistical comparable results, the number of subjects
per group to be included in the analysis was calculated. Considering a
40% difference among groups to be significant, and a 95% probability
of obtaining a significant difference among groups at the 5% level, the
resulting number of subjects per group was set in 64.
With the collaboration of the Municipal Electoral Registry Office, a
letter explaining the purpose of the study and the informed consent
were distributed to 5% (1131 subjects) of the age group considered
living in Sassari. A total of 577 subjects (51.0% acceptance rate), aged
between 30 and 45 years, accepted to participate and were examined
for conditions that would preclude participation. The flow-chart, dis-
played in Fig. 1, shows the design of the study.
The inclusion criteria were: age range between 30 and 45 years;
presence of a minimum of 12 natural teeth; presence of at least one
cavitated caries lesion (ICDAS score 5), but no more than three; a
salivary concentration of mutans streptococci ≥105 CFU/ml saliva; no
current periodontitis (no sites of probing pocket depth ≥5 mm or at-
tachment loss of ≥2 mm, apart from gingival recession); absence of
dysfunction of temporo-mandibular joint; good general health as as-
sessed by a medical questionnaire; no use of antibiotics or participation
in a clinical study in the previous 30 days; no allergy to any of the
ingredients of the study products; no orthodontic banding or removable
prosthesis.
Those participants who referred to consume more than three pieces
of sugar-free chewing gum a day were excluded. The elected partici-
pants agreed not to consume any other chewing gums than those sup-
plied for the study.
All participants were residents in an area with a low natural fluoride
content in the tap water (0.04 mg/l) (http://www.abbanoa.it/distretto-
6-sassari1), but they reported to use a fluoridated toothpaste on a
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regular basis.
Randomization was performed (G. Campus) using Excel 2014 in
permuted blocks of 2 or 4 with a random variation of the blocking
number, and 3 groups were created: (1) the first group (Pols) received
sugar-free gums containing several polyols except Xylitol; (2) the
second group (Xyl) received gums containing the same polyols mixture
plus a low amount of Xylitol and (3) the third group (Xyl + Mag) re-
ceived the polyols mixture plus the low amount of Xylitol and mag-
nolia. All personnel involved into the study were blinded to the parti-
cipant assignment.
In total 480 subjects were examined and 331 fulfilled the inclusion
criteria. Two-hundred seventy-one subjects accepted to be enrolled in
the trial.
2.6. Clinical examination
The clinical examination of the enrolled sample was performed at
baseline (t0) and repeated at the end of the chewing-gum administra-
tion period (12 months, t2) and at the end of the experimental period
(24 months, t3).
The subjects were examined using a mouth mirror, a ball ended
probe and artificial light in a dental chair. The ICDAS index was used to
register caries at tooth level as initial or moderate or severe lesions, the
number of filled teeth and the missing teeth for caries (Ismail et al.,
2007). The bleeding on probing score was registered in all subjects. At
baseline, the examiner that performed all the dental screenings was
trained and calibrated by a benchmark examiner. Baseline training
consisted in one-day (6 h) theoretical course, followed by examination
of 54 extracted teeth plus a session of 120 photographs of extracted
teeth. Two days after the theoretical course a clinical training involving
55 adults was performed. The subjects were re-examined after 72 h.
Inter-examiner reliability with the benchmarck examiner was evaluated
using fixed-effects analysis of variance. Intra-examiner reproducibility
was assessed as the percentage of agreement using Cohen’s kappa sta-
tistic (Castiglia, Campus, Solinas, Maida, & Strohmenger, 2007). Good
reliability was found between examiner and benchmark, (p = 0.15)
with a low mean square of error (0.47). Intra-examiner reliability was
also high (Cohen’s Kappa statistic = 0.88). Interim and follow-up
training was also performed.
The subjects were instructed to chew a total of 5 pellets for 5 min
divided into 3 intakes a day (2 in the morning, 2 after the midday meal
and 1 in the afternoon). Thus, the total daily intake of Magnolol and
Honokiol was 12 mg/day, and for Xylitol was 2.5 g/day. The subjects
were asked to make no changes in their dietary and oral hygiene habits.
Tooth brushing was not allowed for at least 1 h after the use of chewing
gum. All subjects received a fluoridated toothpaste containing
1450 ppm NaF (Mentadent P; Unilever Italia, Milan, Italy) to be used
during the experimental period. They were asked to avoid any other
oral hygiene adjuvant and any commercial Xylitol or Sorbitol products
throughout the study period. The body’s tolerance of different polyols
and Magnolia extract was assessed by means of a questionnaire ad-
ministered to the participants shortly after the gum distribution had
started and 6 months later, while the study was still proceeding. The
questions focused on the potential side effects of using the gum. In
Fig. 1. Flow-chart of the study.
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order to evaluate the success of the chewing gum intake, participants
were given chewing gums necessary for a single month at a time and
asked to return the empty packs when receiving those for the following
month. At t3 a new questionnaire was submitted to all the participants
to investigate if during the no chewing gum period (from t2 to t3) a use
of sugar-free chewing gums continued.
2.7. Plaque-pH measurements
Interproximal-plaque pH was evaluated using pH indicator strips
(Carlen, Hassan, & Lingstrom, 2010), which measure a pH value in the
range of 4.0–7.0 (Spezialindikator, pH range 4.0–7.0; Merck, Darm-
stadt, Germany). The strips determine changes in plaque pH, dis-
criminating differences at the level of 0.2–0.5 pH units and they are
easy to use. The strips were cut into 4 pieces (approx. 2 mm in width) in
order to get a strip that could be easily inserted into the interproximal
space and held in situ for 10 s, after which it was removed, and its
colour compared to the colour index scheme supplied by the manu-
facturer.
For each subject, 3 measurements were carried out in 2 sites, be-
tween the 2nd premolar and the 1st molar right and left of the upper
jaw. Measurements were performed before and at 2, 5, 10, 15, 20 and
30 min after a mouth rinse with 10% sucrose. All measurements were
carried out by the one examiner. Plaque pH was assessed at baseline
(t0), after 6 (t1), 12 months (t2) of chewing gum use and 12 months after
the cessation of the chewing gum use (t3).
2.8. Microbiological evaluation
An evaluation of the number of mutans streptococci (MS) con-
centration in saliva was performed at baseline (t0) and six (t1), twelve
(t2) and twenty-four (t3) months from baseline. No-stimulated whole
saliva was collected over 150 s in sterile vials (Nunc, Kamstrup,
Denmark). The samples were transported to the Department of
Microbiology of the University of Sassari and processed within 45 min
after collection.
Mutans streptococci counts in saliva were assessed and categorized
using the dip-slide technique (CTR bacteria, Ivoclar Vivadent,
Germany).
2.9. Statistical analysis
The Data on caries were based considered the tooth as the unit of
analysis; the net caries increment for initial, moderate and severe caries
level, using ICDAS (Δ-initial, Δ-moderate and Δ-severe), was calculated.
Differences between groups in terms of the caries increment were
evaluated using the nonparametric Mann–Whitney U test.
The data on inter-proximal plaque pH and gingival bleeding scores
at t0, t1, t2 and t3 were analysed for statistically significant differences
using repeated measures of ANOVA. Due to the non-symmetry, the log-
linear regression, using robust SEs, was used to compare the data of the
three interventions (Schafer, 1997, Chapter 8).
Differences in proportion relating to microbiological counts at
baseline and follow-up were assessed using equality of proportion test.
The efficacy and consequences of treatment were also considered,
calculating the event rate (ER) for each group and the number needed
to treat (NNT) (Laupacis, Sackett, & Roberts, 1988). An event was de-
fined as the change of status at tooth level, i.e. the development of a
new lesion or the progression of an existing lesion to a more severe level
or the change of a tooth previously affected in a filled or a missing tooth
during the 2-year follow-up period. All data were analysed using the
software STATA® (v13 for Macintosh). For all statistical analysis, the
statistical significance level was set at α = 0.05.
The number needed to treat (NNT) is the estimated number of pa-
tients who need to be treated with the new treatment rather than the
standard treatment (or no treatment) for one additional patient to
benefit (Altman, 1998). This method of analysis preserves the prog-
nostic balance afforded by randomization.
3. Results
3.1. Magnolia Bark Extract in chewing gum
The release of the two neolignans was 86,86% with a 95%Confidence
Interval 75.43–96.82 and 60,10% (95%CI = 49.49–71.29) for magnolol
and honokiol respectively (data not in tables).
3.2. Clinical examination
A total of 194 subjects (71.22% of the initial sample) completed the
trial, 64 in the polyols group (Pols), 66 in the Xylitol group (Xyl) and 64
in the Xylitol plus Magnolia group (Xyl + Mag) (Fig. 1). The highest
number of drop-out was reported at t1 with the discontinued inter-
vention as the main reason for dropping out. No side-effects were ob-
served in any subjects. Moreover, the use of chewing gum after the
experimental period was fairly insignificant; only 28 (10.9%) subjects
reported the regular use (once a day or more) of sugar-free chewing
gum (data not in table).
No statistically significant differences between groups were re-
corded at baseline regarding caries severity and no gender difference
was also observed (data not in table). At2 the Δ-values of the initial
caries lesions measured in the three groups were statistically different
(p = 0.02) and this difference increased at t3 (p < 0.01). The mod-
erate caries level did not differ among the three groups in any eva-
luations (p = 0.08 at t2 and 0.10 at t3, respectively). The analysis of the
caries increment for the severe lesions level revealed a statistically
significant difference among groups (p = 0.02 at t2 and p < 0.01 at
t3). The caries increment was always lower in the Xylitol plus Magnolia
Table 1
Caries data (ICDAS) at t0 (baseline) and caries increment (Δ) between t0 and t2 (12-month examination) and between t0 and t3 (24-month examination) at different
threshold levels are shown. Differences between groups were evaluated using the nonparametric Mann–Whitney U test.
Caries at baseline Caries increment (Δ) Filled teeth (Δ)
mean (SD) mean (SD) mean (SD)
t0 t2 t3 t3
Chewing gums (baseline) (Δ0–12 months) (Δ0–24 months) (Δ0–24 months)
Initial Moderate Severe Initial Moderate Severe Initial Moderate Severe
Polyols 6.92 (11.9) 3.83 (7.72) 2.11 (2.65) 0.09 (0.15) 0.10 (0.35) 0.18 (0.38) 0.20 (0.67) 0.18 (0.72) 0.44 (0.73) 1.12 (2.89)
Xylitol 7.10 (12.0) 3.78 (8.28) 2.20 (2.86) 0.05 (0.12) 0.07 (0.23) 0.11 (0.12) 0.14 (0.37) 0.16 (0.82) 0.30 (0.52) 0.73 (1.41)
Magnolia 7.21(11.73) 4.17 (7.49) 2.18 (3.01) 0.04 (0.14) 0.06 (0.42) 0.09 (0.44) 0.10 (0.34) 0.14 (0.51) 0.25 (0.38) 0.78 (1.34)
p-value 0.53 0.26 0.62 0.02 0.08 0.02 <0.01 0.10 <0.01 0.03
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group compared to the Xylitol and the Polyol groups in any evaluation.
Finally, fillings increment does not significantly differ among groups
(Table 1).
The number of caries lesions recorded at baseline, at 12 months and
24 months follow-up evaluations and the difference (Δ) between
baseline and 24 months follow-up evaluation was compared among
Fig. 2. Number of caries lesions (Initial, Moderate and Severe) recorded during the trial.
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groups considering the subjects who completed the trial. The difference
in the number of severe caries lesions between baseline and the
24 months follow-up examination was statistically significant lower in
Xyl + Mag group (χ2 = 4.79 p < 0.02) compared to the other groups
(Fig. 2).
Subjects treated with Magnolia chewing-gums had a Reduction of
Risk Rate (RRR) of 39% respect to those treated with Polyols with a
Number Needed to Treat (NNT) of 32; subjects treated with Xylitol
chewing-gums had a RRR of 23% respect to those treated with polyols
with a Number Needed to Treat (NNT) of 55. Finally, subjects treated
with Xylitol plus Magnolia chewing gum had an RRR of 22% respect to
those treated with Xylitol only with a NNT of 75. The event rate was
0.087 in the Pols group, 0.052 in the Xyl + Mag group and 0.066 in the
Xyl group (Table 2).
Subjects from the magnolia and xylitol groups showed a sig-
nificantly lower gingival bleeding scores at the end of the chewing
period (t2) compared to baseline (p = 0.01 and< 0.01, respectively). A
reduction in the bleeding score was also noted for the polyols group
even if not statistically significant (Table 3).
3.3. Plaque-pH measurements
At baseline (t0), plaque pH expressed as the areas under the curve
(AUC) at pH 5.7 and 6.2 and the salivary MS concentration were similar
in the three groups, with no statistically significant differences
(Table 4). Mean AUCs were statistically significantly different at t2 and
t3 in the three groups (AUC5.7 p = 0.03 and AUC6.2 p = 0.04 at t2 and
p = 0.04 and 0.05 respectively at t3). During the trial, intra-group
differences were also observed for Xyl and Xyl + Mag group. AUC5.7
and AUC6.2 decreased in both groups, with a wider reduction in
Xyl + Mag group (AUC5.7 p = 0.02 for Xyl group and p < 0.01 for
Xyl + Mag group and AUC6.2 p < 0.01 for both).
3.4. Microbiological evaluation
At baseline, salivary mutans streptococci in all the subjects had level
of ≥105 CFU/ml as an inclusion criterion for the trial. A decrease of MS
concentration was noted in each group during the experimental period,
but the differences reached a statistically significant value for
Xyl + Mag and Xyl group only (p < 0.01 for both). The comparison
among the three groups showed a statistically significant difference at
t2 (p = 0.02) and t3 (p = 0.03) (data not in Tables).
4. Discussion
The purpose of this RCT was to assess the caries preventive effect of
the long-term use of sugar-free chewing-gums in a high-risk adult po-
pulation. To elucidate this hypothesis, a three-arm randomised clinical
trial was designed and carried out. Three types of chewing gums were
included into the trial: a polyol chewing gum, a low-dosage Xylitol
chewing gum and a chewing gum contains Xylitol plus Magnolia Bark
Extract (MBE). The MBE was found to be effectively released in a 5 min
chewing time. In a previous study (Greenberg et al., 2007) MBE release
was tested at 6, 12 and 20 min of chewing and it was found to be about
50–60% at all time points when included in the gum coating, while the
release was negligible, when the extract was included in the center. The
chewing gum dragees used in one arm of the present clinical study
contained MBE, which was included in the gum coating. The release
was determined according to literature, however it was found to be
slightly higher. We hypothesize that this difference may be due to the
formulations of gum base used in the present and int the previous study.
However the main point of the effective release of active neolignans
during gum chewing, when they are included in the gum coating, was
confirmed.
The trial focused on the concentration of cariogenic bacteria in
saliva, plaque acidogenicity and caries increment over a two-year
period, during which no other community-based caries prevention
strategies were carried out.
At the end of the follow-up, a statistically significant difference in
caries lesions increment and severity compared to baseline was ob-
served among groups. Subjects using the Xylitol plus Magnolia chewing
gum showed the lowest caries increment of new lesions, the lowest
caries progression and the lowest number of restorative treatments
compared to the Xylitol and the Polyol groups.
Today, non-fermentable sweeteners are incorporated into many
products, such as chewing-gums. The main sugar substitutes used in
chewing-gum are polyols, especially Xylitol (Bar, 1988). Although the
mechanisms of Xylitol are not fully known, several studies have de-
monstrated its benefits both as non-cariogenic and even cariostatic
agent (Campus et al., 2013; Cocco et al., 2017). Magnolia Bark Extract
is a traditional Chinese medicine that has demonstrated an antibacterial
effect against oral microorganisms (Brambilla, Cagetti, Ionescu,
Campus, & Lingstrom, 2014; Chang, Lee, Ku, Bae, & Chung, 1998;
Greenberg, Urnezis, & Tian, 2007; Ho, Tsai, Chen, Huang, & Lin, 2001;
Namba, Tsunezuka, & Hattori, 1982). MBE showed promising results
reducing oral bacteria, including mutans steptococci by 43.0% at
40 min (Greenberg et al., 2007; Greenberg, Dodds, & Tian, 2008). Even
if there is only one paper (Sakaue et al., 2016) that describes on the
different actions of two main constituents magnolol and honokiol; the
Table 2
Effectiveness of the treatment. An event was defined as the change of status at
tooth level.
Events Non Events Event Rate
Polyols 112 1290 0.087
Magnolia 66 1298 0.052
z = 3.33p < 0.01 RR = 0.61 95%CI = 0.45/0.81 NNT = 32 95%CI = 20.10/75.50
Polyols 112 1290 0.087
Xylitol 85 1291 0.066
z = 1.85p = 0.06 RR = 0.77 95%CI = 0.59/1.01 NNT = 55 95%CI = 1034.43/26.89
Xylitol 85 1291 0.066
Magnolia 66 1298 0.052
z = 1.53p = 0.13 RR = 0.78 95%CI = 0.57/1.07 NNT = 75 95%CI = 270.59/32.82
Table 3
Gingival bleeding scores in the three groups.
Gingival bleeding score
Gum use No-Gum use
t0 (Baseline) t1 (6 months) t2 (12 months) t3 (24 months) p-value
% (95%CI) % (95%CI) % (95%CI) % (95%CI)) (repeated Anova)
Polyols 32.14 (25.14–38.94) 29.45 (21.54–38.27) 27.32 (20.49–34.45) 29.48 (21.20–37.21) 0.07
Xylitol 32.81 (25.78–39.25) 27.03 (21.74–33.57) 24.65 (15.74–33.37) 26.85 (18.98–34.21) 0.01
Xylitol + Magnolia 33.05 (26.14–36.24) 25.86 (14.73–32.80) 20.87 (11.44–30.31) 22.24 (17.41–30.55) <0.01
p-value (One-way Anova) 0.32 0.03 <0.01 0.02
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different concentration of the two products on the chewing-gums used
in the trial might explain the highr antibacterial and caries preventive
effect of the chewing-gum enriched by MBE plus Xylitol respect to
chewing enriched by Xylitol.
The low number of new caries lesions recorded twelve months after
the end of the chewing gum use in Xylitol and in Xylitol plus Magnolia
group in particular is probably related to the long-term effect of Xylitol
that persists over time. In a recent placebo-controlled RCT (Bader et al.,
2013), adults at high caries risk consumed 5 g/day of Xylitol through
lozenges during a 33-month period. No significant effect was observed
regarding caries increment even if a quite high dose was used. The
different Xylitol administration modalities, lozenges versus chewing
gum and the no specific administration time versus far from the main
meals, might explained this apparent contradiction. The addition of
Magnolia Bark extracts to the Xylitol chewing seems to increase the
lowering effect on caries increment, both on the development of new
lesions and on the progression of the existing lesions. This result is
totally new since no RCT are available in literature aiming to verify the
effect of Magnolia extracts on a clinical outcome related to caries, so it
is not possible to compare the results of the present investigation to
those of previous studies. A combined effect of Xylitol and Magnolia
might be speculated, since both ingredients have shown to be effective
in reducing cariogenic bacteria both in vitro and in vivo (Campus et al.,
2011).
Moreover, this study investigated the effects of the three sugar-free
chewing gums on two risk factors of caries, salivary mutans streptococci
and interproximal plaque acidogenicity. Considering the effect on mu-
tans streptococci, the one-year use of the chewing-gum containing MBE
and Xylitol showed to be more efficient in the reduction of the con-
centration of the cariogenic bacteria in saliva than Xylitol and Polyol
chewing gum. Nevertheless, twelve months later the end of the chewing
gum use, the effect on MS of Xylitol chewing and MBE plus Xylitol tends
to be similar in both groups, assuming that the effect of MBE is lost
overtime while that of Xylitol persists overtime.
Regarding plaque pH, comparisons among groups revealed statisti-
cally significantly differences, showing that the areas under the curve
both for enamel and dentine dissolution were less pronounced in the
Xylitol plus Magnolia group and in Xylitol group both at the end of the
chewing gum use and one-year after compared to Polyol group. These
pH figures are related to the trend of cariogenic bacteria during the
two-year period described above. Xylitol plus Magnolia chewing gum
also showed an effect on gingival tissue, measured through bleeding on
probing, indicating that the use of chewing-gums might improve gin-
gival health by reducing gingival bleeding. The affinity of MBE for oral
Gram-negative bacteria increasing their cell surface hydrophobicity
might be linked to this outcome resulting in a decreased accumulation
of dental plaque and reduction of gingival inflammation (Walker et al.,
2013).
This study holds almost unique characteristics like the adult popu-
lation considered, the length of the administration, the quite long
follow-up period, but above all the evaluation for the first time the
effect of a chewing gum containing MBE on the incidence of caries as
well as on caries risk factors within the same study. On one end this
study reinforces the hypothesis that chewing a gum containing Xylitol
and MBE is able to reduce caries risk, decreasing the number of mutans
streptococci and the production of acids and caries increment. On the
other hand, as it was described in the previous paper (Cocco et al.,
2017), the population enrolled for this trial was selected at high risk of
caries and belonged to an age range in which the regular use of chewing
gums is not common, and this might explain the quite high drop-out
rate recorded at the 12 months interim examination. Therefore, it is
questionable whether or not the selected sample is representative for
the general adult population of that age range.
Caries still remains a social problem even in industrialized country
as Italy where socioeconomic inequalities across a broad spectrum of
oral indicators reflecting unmet needs are described (Arrica et al.,
2017). Moreover, since dental care is not covered by the National
Health System, it has a great importance to promote effective low-cost
caries prevention strategies and the administration of a chewing gum
even if for a long period, might be an interesting possibility. It was
recently postulated that the elevation of the consumption of sugar-free
chewing gum in Germany to the level of Finland would lead to a con-
siderable benefit for cost saving and oral health (Zimmer, Spyra,
Kreimendahl, Blaich, & Rychlik, 2018). The present RCT contributes to
promote this kind of low-cost intervention.
In conclusion, the present study provides robust but still non-con-
clusive evidence on the efficacy of Xylitol plus Magnolia chewing gum
compared to a Xylitol and Polyols gum to reduce caries risk factors and
to prevent caries lesions, therefore being possible to accept the study’s
hypothesis. A clinical suggestion deriving from the results of this trial is
the opportunity to administer daily Xylitol plus Magnolia gum to high
caries risk subjects. To attest the superiority or equivalence of Xylitol
plus Magnolia gums according to the EFSA guidelines, however, at least
two independent clinical studies are needed. Thus, future studies are
Table 4
Plaque pH. Representation of AUC5.7 and AUC6.2 expressed as mean (SE). Salivary mutans streptococci. Concentrations as Log10 CFU/ml in saliva mean (SE) at the
different time intervals (t0, t1, t2 and t3) in the three groups.
AUC5.7
Gum use No-Gum use
t0 (Baseline) t1 (6 months) t2 (12 months) t3 (24 months) p-value
mean (SD) mean (SD) mean (SD) mean (SD) (One-way Anova)
Polyols 11.68 (0.59) 11.44 (0.54) 9.53 (0.35) 11.45 (0.20) 0.08
Xylitol 11.45 (0.46) 11.27 (0.33) 9.65 (0.38) 9.85 (0.34) 0.02
Magnolia 11.32 (0.24) 10.66 (0.73) 7.87 (0.31) 8.06 (0.41) <0.01
p-value (One-way Anova) 0.32 0.27 0.03 0.04
AUC6.2
Polyols 21.56 (0.24) 18.94 (0.81) 18.98 (0.77) 19.75 (0.16) 0.12
Xylitol 22.78 (0.57) 20.11 (0.48) 18.61 (0.71) 18.67 (0.56) <0.01
Magnolia 23.97 (0.53) 21.08 (1.01) 15.89 (0.88) 16.26 (0.78) <0.01
p-value One-way Anova 0.32 0.27 0.04 0.05
Salivary mutans streptococci
Polyols 5.32 (0.41) 5.22 (0.21) 5.33 (0.37) 5.33 (0.42) 0.42
Xylitol 5.41 (0.26) 5.33 (0.43) 5.16 (0.44) 5.15 (0.56) <0.01
Magnolia 5.40 (0.12) 5.33 (0.42) 5.12 (0.30) 5.14 (0.31) <0.01
p-value (One-way Anova) 0.20 0.47 0.03 0.02
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still necessary, aiming at assessing the effects of the products not only in
caries progression, but also in the reversal of non-cavitated lesions.
5. Ethics statements
The study was approved by the Ethics Committee of the University
of Sassari (n°1083/L 23/ 07/2012), and registered (Protocol
Registration Receipt NCT02310308) at http://www.clinicaltrial.gov.
All performed procedures were in accordance with the ethical standards
of the 1964 Helsinki Declaration and its later amendments.
A letter explaining the purpose of the study and the informed con-
sent were distributed to 1131 subjects of the age group considered. A
total of 577 subjects (51.0% acceptance rate), accepted to participate.
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